18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

NCT05155046 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

NIH

Sponsor class

Conditions

Localized Prostate Cancer

Interventions

DRUG: 18F-DCFPyL

Sponsor

National Cancer Institute (NCI)